SFRP2 and breast carcinoma: In both MCF7 and MDA-MB-231 breast cancer cells in which SIRT1H363Y was expressed through retroviral infection, we observed a re-expression of SFRP1and SFRP2 (Figure 2E and 2F [left panel]).